Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study

Abstract Impaired left atrial (LA) function in heart failure with preserved ejection fraction (HFpEF) is associated with adverse outcomes. A subgroup of HFpEF may have LA myopathy out of proportion to left ventricular (LV) dysfunction; therefore, we sought to characterize HFpEF patients with disprop...

Full description

Bibliographic Details
Main Authors: Ravi B. Patel, Carolyn S. P. Lam, Sara Svedlund, Antti Saraste, Camilla Hage, Ru-San Tan, Lauren Beussink-Nelson, Jasper Tromp, Cynthia Sanchez, Joyce Njoroge, Stanley A. Swat, Ulrika Ljung Faxén, Maria Lagerstrom Fermer, Ashwin Venkateshvaran, Li-Ming Gan, Lars H. Lund, Sanjiv J. Shah
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-84133-9
id doaj-e093b432c8384f01a9adf34cc50f376f
record_format Article
spelling doaj-e093b432c8384f01a9adf34cc50f376f2021-03-11T12:15:49ZengNature Publishing GroupScientific Reports2045-23222021-03-0111111110.1038/s41598-021-84133-9Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF studyRavi B. Patel0Carolyn S. P. Lam1Sara Svedlund2Antti Saraste3Camilla Hage4Ru-San Tan5Lauren Beussink-Nelson6Jasper Tromp7Cynthia Sanchez8Joyce Njoroge9Stanley A. Swat10Ulrika Ljung Faxén11Maria Lagerstrom Fermer12Ashwin Venkateshvaran13Li-Ming Gan14Lars H. Lund15Sanjiv J. Shah16Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of MedicineNational Heart Centre Singapore, Duke-National University of SingaporeDepartment of Clinical Physiology, Institute of Medicine, Sahlgrenska University Hospital, University of GothenburgHeart Center, Turku University Hospital, University of TurkuDepartment of Medicine, Cardiology Unit and Heart and Vascular Theme, Karolinska InstitutetNational Heart Centre Singapore, Duke-National University of SingaporeDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of MedicineNational Heart Centre Singapore, Duke-National University of SingaporeDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of MedicineDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of MedicineDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of MedicineDepartment of Medicine, Cardiology Unit and Heart and Vascular Theme, Karolinska InstitutetEarly Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPhamaceuticals R&D, AstraZenecaDepartment of Medicine, Cardiology Unit and Heart and Vascular Theme, Karolinska InstitutetEarly Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPhamaceuticals R&D, AstraZenecaDepartment of Medicine, Cardiology Unit and Heart and Vascular Theme, Karolinska InstitutetDivision of Cardiology, Department of Medicine, Northwestern University Feinberg School of MedicineAbstract Impaired left atrial (LA) function in heart failure with preserved ejection fraction (HFpEF) is associated with adverse outcomes. A subgroup of HFpEF may have LA myopathy out of proportion to left ventricular (LV) dysfunction; therefore, we sought to characterize HFpEF patients with disproportionate LA myopathy. In the prospective, multicenter, Prevalence of Microvascular Dysfunction in HFpEF study, we defined disproportionate LA myopathy based on degree of LA reservoir strain abnormality in relation to LV myopathy (LV global longitudinal strain [GLS]) by calculating the residuals from a linear regression of LA reservoir strain and LV GLS. We evaluated associations of disproportionate LA myopathy with hemodynamics and performed a plasma proteomic analysis to identify proteins associated with disproportionate LA myopathy; proteins were validated in an independent sample. Disproportionate LA myopathy correlated with better LV diastolic function but was associated with lower stroke volume reserve after passive leg raise independent of atrial fibrillation (AF). Additionally, disproportionate LA myopathy was associated with higher pulmonary artery systolic pressure, higher pulmonary vascular resistance, and lower coronary flow reserve. Of 248 proteins, we identified and validated 5 proteins (involved in cardiomyocyte stretch, extracellular matrix remodeling, and inflammation) that were associated with disproportionate LA myopathy independent of AF. In HFpEF, LA myopathy may exist out of proportion to LV myopathy. Disproportionate LA myopathy is a distinct HFpEF subtype associated with worse hemodynamics and a distinct proteomic signature, independent of AF.https://doi.org/10.1038/s41598-021-84133-9
collection DOAJ
language English
format Article
sources DOAJ
author Ravi B. Patel
Carolyn S. P. Lam
Sara Svedlund
Antti Saraste
Camilla Hage
Ru-San Tan
Lauren Beussink-Nelson
Jasper Tromp
Cynthia Sanchez
Joyce Njoroge
Stanley A. Swat
Ulrika Ljung Faxén
Maria Lagerstrom Fermer
Ashwin Venkateshvaran
Li-Ming Gan
Lars H. Lund
Sanjiv J. Shah
spellingShingle Ravi B. Patel
Carolyn S. P. Lam
Sara Svedlund
Antti Saraste
Camilla Hage
Ru-San Tan
Lauren Beussink-Nelson
Jasper Tromp
Cynthia Sanchez
Joyce Njoroge
Stanley A. Swat
Ulrika Ljung Faxén
Maria Lagerstrom Fermer
Ashwin Venkateshvaran
Li-Ming Gan
Lars H. Lund
Sanjiv J. Shah
Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
Scientific Reports
author_facet Ravi B. Patel
Carolyn S. P. Lam
Sara Svedlund
Antti Saraste
Camilla Hage
Ru-San Tan
Lauren Beussink-Nelson
Jasper Tromp
Cynthia Sanchez
Joyce Njoroge
Stanley A. Swat
Ulrika Ljung Faxén
Maria Lagerstrom Fermer
Ashwin Venkateshvaran
Li-Ming Gan
Lars H. Lund
Sanjiv J. Shah
author_sort Ravi B. Patel
title Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
title_short Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
title_full Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
title_fullStr Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
title_full_unstemmed Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
title_sort disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the promis-hfpef study
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-03-01
description Abstract Impaired left atrial (LA) function in heart failure with preserved ejection fraction (HFpEF) is associated with adverse outcomes. A subgroup of HFpEF may have LA myopathy out of proportion to left ventricular (LV) dysfunction; therefore, we sought to characterize HFpEF patients with disproportionate LA myopathy. In the prospective, multicenter, Prevalence of Microvascular Dysfunction in HFpEF study, we defined disproportionate LA myopathy based on degree of LA reservoir strain abnormality in relation to LV myopathy (LV global longitudinal strain [GLS]) by calculating the residuals from a linear regression of LA reservoir strain and LV GLS. We evaluated associations of disproportionate LA myopathy with hemodynamics and performed a plasma proteomic analysis to identify proteins associated with disproportionate LA myopathy; proteins were validated in an independent sample. Disproportionate LA myopathy correlated with better LV diastolic function but was associated with lower stroke volume reserve after passive leg raise independent of atrial fibrillation (AF). Additionally, disproportionate LA myopathy was associated with higher pulmonary artery systolic pressure, higher pulmonary vascular resistance, and lower coronary flow reserve. Of 248 proteins, we identified and validated 5 proteins (involved in cardiomyocyte stretch, extracellular matrix remodeling, and inflammation) that were associated with disproportionate LA myopathy independent of AF. In HFpEF, LA myopathy may exist out of proportion to LV myopathy. Disproportionate LA myopathy is a distinct HFpEF subtype associated with worse hemodynamics and a distinct proteomic signature, independent of AF.
url https://doi.org/10.1038/s41598-021-84133-9
work_keys_str_mv AT ravibpatel disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT carolynsplam disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT sarasvedlund disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT anttisaraste disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT camillahage disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT rusantan disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT laurenbeussinknelson disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT jaspertromp disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT cynthiasanchez disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT joycenjoroge disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT stanleyaswat disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT ulrikaljungfaxen disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT marialagerstromfermer disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT ashwinvenkateshvaran disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT liminggan disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT larshlund disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
AT sanjivjshah disproportionateleftatrialmyopathyinheartfailurewithpreservedejectionfractionamongparticipantsofthepromishfpefstudy
_version_ 1724224644531093504